<DOC>
	<DOCNO>NCT00629135</DOCNO>
	<brief_summary>The study contemplate antibiotic therapy intraabdominal abscess . These abscesses serious problem surgical practice . Associated pathophysiologic effect example peritonitis may become life threaten may lead extend period morbidity prolong hospitalization . The objective sudy evaluate whether combination Moxifloxacin Metronidazole equivalent Piperacillin / Tazobactam regard clinical outcome eradication aerobe anaerobe pathogens patient intra-abdominal abscess .</brief_summary>
	<brief_title>Moxifloxacin Plus Metronidazole Versus Piperacillin/Tazobactam Treatment Patients With Intra-abdominal Abscesses</brief_title>
	<detailed_description>The study interventional prospective , comparative , open-label , randomise single-centre study . Adult patient intra-abdominal abscess match criterion include enrol study randomise one Groups : 1 . Moxifloxacin 400 mg , administer intravenously daily combination Metronidazole 500 mg , administer two time daily intravenously , follow oral medication Moxifloxacin 400 mg daily Metronidazole 500 mg twice daily . 2 . Piperacillin / Tazobactam 4,5 g administer intravenously three time daily . Primary study endpoint : Clinical success / failure rate Test-of-Cure visit . Secondary study endpoint : -Bacteriological response TOC , -Clinical + Bacteriological response End-of-Treatment-visit , - Course disease basis clinical laboratory parameter , -Time discharge hospital , -Duration hospitalization post-operatively , - safety tolerability study medication , -cost effectiveness treatment regime .</detailed_description>
	<mesh_term>Abscess</mesh_term>
	<mesh_term>Abdominal Abscess</mesh_term>
	<mesh_term>Tazobactam</mesh_term>
	<mesh_term>Penicillanic Acid</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Piperacillin , tazobactam drug combination</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Patients attain full age ( 18 year ) intraabdominal abscess document : A ) Laparotomy reveal intraabdominal abscess macroscopic gastrointestinal perforation OR B ) Suspected intraabdominal abscess schedule operation least three follow criterion : fever , leucocytosis , symptom referable abdominal cavity ( nausea , pain ) , tenderness without rebound / abdominal wall rigidity , radiological evidence abscess gastrointestinal perforation . Patients follow : indwell peritoneal catheter , presume spontaneous bacterial peritonits , peripancreatic sepsis infection secondary pancreatitis , peptic traumatic perforation gastrointestinal tract &lt; 24 h duration , traumatic perforation small large bowel &lt; 12h duration , transmural necrosis intestine due acute embolic , thrombotic obstructive occlusion , acute cholecystitis , appendicitis without perforation abscess , require open abdomen technique management , gynaecological infection , know hypersensivity study drug , lifethreatening disease life expectancy le 48 hour , neutropenia neutrophil count &lt; 1000 cells/µl , receive chronic treatment imunosuppressant therapy , HIVseropositives CD4 count &lt; 200 cells/µl , end stage hepatic cirrhosis CHILD PUGH C , central peripheral neuropathy , bradycardia , symptomatic dysrhythmia medical history , syndromes QTc prolongation use concomittant medicament report increase QT interval , disorder electrolyte balance , previous history tendinopathy quinolones , previously enrol trial use investigational drug within previous 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>abscess</keyword>
	<keyword>intraabdominal abscess</keyword>
	<keyword>Moxifloxacine</keyword>
	<keyword>Moxifloxacin</keyword>
	<keyword>Metronidazole</keyword>
	<keyword>Tazobactam</keyword>
	<keyword>Piperacilline</keyword>
	<keyword>Piperacillin</keyword>
	<keyword>Tazobac</keyword>
</DOC>